
AIM-quoted Ascribe reported a higher full year pretax profit and said its management buyout talks are still continuing, which may or may not lead to an offer being made for the company.
For the year to end-June, the healthcare technology provider posted a pretax profit of £3.8m from £3.0m a year earlier, as sales increased 14% to £17.4m.
The company also said it is confident it will continue to meet management expectations in 2008/2009.